ORIC Pharmaceuticals Q3 EPS $(0.44) Misses $(0.39) Estimate

Benzinga · 2d ago
ORIC Pharmaceuticals (NASDAQ:ORIC) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.39) by 12.82 percent. This is a 33.33 percent decrease over losses of $(0.33) per share from the same period last year.